Financhill
Sell
49

FULC Quote, Financials, Valuation and Earnings

Last price:
$8.76
Seasonality move :
23.58%
Day range:
$8.68 - $9.29
52-week range:
$2.32 - $12.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.39x
Volume:
821.2K
Avg. volume:
827.1K
1-year change:
149.57%
Market cap:
$474.1M
Revenue:
$80M
EPS (TTM):
-$1.18

Earnings Data

Next earnings date for FULC
Feb 24
2026
Most recent earnings per share
-$0.31
Missed by $0.02
(Oct 29/2025)
Consensus Estimate
-$0.29
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FULC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 -- -- -- -$0.32 --
10/29/2025 Q3 -- -- -$0.31 -$0.29 -$0.02
07/29/2025 Q2 -- -- -$0.28 -$0.29 $0.01
05/13/2025 Q1 -- -- -$0.28 -$0.33 $0.04
02/25/2025 Q4 -- -- -$0.31 -$0.29 -$0.02
11/13/2024 Q3 -- -- -$0.35 -$0.40 $0.05
07/31/2024 Q2 $41.1M $80M $0.87 $0.06 $0.81
05/13/2024 Q1 $360.1K -- -$0.43 -$0.44 $0.00
02/27/2024 Q4 $394.8K $871K -$0.40 -$0.43 $0.03
11/07/2023 Q3 $1.1M $759K -$0.39 -$0.44 $0.05
08/03/2023 Q2 -- $880K -$0.38 -- --
05/15/2023 Q1 -- $295K -$0.41 -- --
03/09/2023 Q4 -- $685K -$0.50 -- --
11/08/2022 Q3 -- $1.2M -$0.51 -- --
08/11/2022 Q2 -- $1.9M -$0.83 -- --
05/09/2022 Q1 -- $2.6M -$0.64 -- --
03/03/2022 Q4 -- $5.1M -$0.58 -- --
11/04/2021 Q3 -- $4.9M -$0.57 -- --
08/10/2021 Q2 -- $4.4M -$0.60 -- --
05/06/2021 Q1 -- $4.8M -$0.54 -- --
03/04/2021 Q4 -- $4.2M -$0.64 -- --
11/10/2020 Q3 -- $1.8M -$0.70 -- --
08/11/2020 Q2 -- $2M -$0.66 -- --
05/13/2020 Q1 -- $750K -$0.81 -- --
03/05/2020 Q4 -- -- -$0.71 -- --
11/14/2019 Q3 -- -- -$0.97 -- --
08/26/2019 Q2 -- -- -$0.71 -- --
03/31/2019 Q1 -- -- -$1.71 -- --
12/31/2018 Q4 -- -- -$0.69 -- --
09/30/2018 Q3 -- -- -$0.64 -- --
06/30/2018 Q2 -- -- -$0.53 -- --
03/31/2018 Q1 -- -- -$0.33 -- --

Fulcrum Therapeutics, Inc. Earnings Questions

  • How Much did Fulcrum Therapeutics, Inc. Generate in Revenue Last Quarter?

    Fulcrum Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Fulcrum Therapeutics, Inc. Beat Earnings Last Quarter?

    Fulcrum Therapeutics, Inc. announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.29 per share.

  • Is Fulcrum Therapeutics, Inc. Profitable?

    Fulcrum Therapeutics, Inc. reported -$300K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Fulcrum Therapeutics, Inc. EPS Next Year?

    Fulcrum Therapeutics, Inc.'s earnings are forecast to decrease from -$0.16 per share to -$0.14 per share next year representing a decrease of -656.53%.

  • When is Fulcrum Therapeutics, Inc.'s Earnings Date?

    Fulcrum Therapeutics, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
39
PSTG alert for Dec 5

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
38
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock